-
1
Antitumor power of oncolytic HSV engineered with IL-12 and IL-15
Published 2025-09-01Subjects: Get full text
Article -
2
Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma
Published 2025-03-01Subjects: Get full text
Article